Beginning January 2026, Texas ambulatory surgery centers face significant new administrative requirements for pain management procedures performed on traditional fee-for-service Medicare patients. While Medicare coverage standards remain unchanged, front-end authorization controls and documentation expectations have become substantially more rigorous.
At Nichols Weitzner Thomas LLP, our healthcare compliance attorneys help Texas ASCs navigate shifting federal requirements while protecting revenue cycles and minimizing operational disruption.
Understanding the WISeR Model
The Centers for Medicare & Medicaid Services is implementing the Wasteful and Inappropriate Service Reduction (WISeR) Model across Texas. WISeR adds prior authorization requirements to select traditional Medicare fee-for-service procedures that were previously subject only to retrospective review.
Critical Implementation Timeline:
- January 1, 2026: WISeR model bcecame effective in Texas
- January 5, 2026: CMS began accepting prior authorization submissions
- January 15, 2026: Prior authorization required for covered services rendered on or after this date
The model applies existing Local Coverage Determination (LCD) and National Coverage Determination (NCD) medical necessity standards without changing coverage criteria. However, the shift from retrospective review to prospective authorization fundamentally changes how ASCs must approach scheduling and documentation.
Which Pain Management Procedures Are Affected?
Epidural Steroid Injections
Epidural steroid injections (ESI) for pain management are explicitly listed in CMS WISeR service categories, including cervical, thoracic, and lumbar ESIs.
Practical implication: Traditional fee-for-service Medicare ESIs performed in Texas ASCs now require prior authorization. Documentation must clearly support the applicable Medicare Administrative Contractor (MAC) LCD requirements.
Procedures Already Subject to CMS Prior Authorization
WISeR operates alongside existing CMS prior authorization programs:
Facet joint interventions have required prior authorization since July 1, 2023. This includes medial branch blocks, radiofrequency ablations, and intra-articular injections.
Implanted spinal neurostimulators (SCS) have required prior authorization since July 1, 2021. Both trial leads and permanent implants fall under this requirement.
The standard CMS determination target is 7 calendar days from submission. Facilities should build this timeline into their scheduling workflows and communicate potential delays to patients at intake.
Medicare Advantage Considerations
Although WISeR applies specifically to traditional fee-for-service Medicare, Texas ASCs should note that Medicare Advantage plans are simultaneously tightening compliance expectations with standardized timelines:
- 7 calendar days for standard decisions
- 72 hours for expedited decisions
For Texas ASCs, this means traditional fee-for-service Medicare and Medicare Advantage workflows should be parallel but tracked separately.
Key Operational Risks
The shift to prospective authorization creates material risks that did not exist under retrospective review:
Scheduling Without Authorization: Scheduling procedures without prior authorization materially increases denial and cash-flow risk. Unlike retrospective denials, prospective denials mean the procedure should not have been performed.
Documentation Gaps: Common issues include insufficient evidence of pain duration and severity, lack of documented functional impairment, missing documentation of failed conservative care, absence of imaging correlation, and inadequate rationale for repeat injections.
Financial Exposure: Cases performed without authorization risk zero reimbursement. Denials become front-end denials before services are rendered, and cash flow disruption is immediate rather than delayed.
Recommended Action Plan for Texas ASCs
1. Implement Mandatory Pre-Schedule Authorization Gates
Create hard stops in your scheduling system for all epidural steroid injections, facet joint interventions, and spinal cord stimulator procedures. Rule: No case scheduled for traditional fee-for-service Medicare patients without an authorization number or documented exemption.
2. Harden Clinical Documentation
Align procedure notes and authorization requests to MAC LCD language. Every authorization submission should clearly document:
- Pain duration and severity with numeric pain scales
- Functional impairment and specific activities the patient cannot perform
- Conservative care attempted and failed with dates and outcomes
- Imaging correlation with specific MRI or CT findings
- Rationale for repeat injections when applicable
3. Build a Single Authorization Tracker
Implement a centralized tracking system capturing payer type, CPT codes, submission dates, authorization status, and denial reasons. This tracker should be accessible to intake staff, precertification teams, and ASC schedulers.
4. Update Patient Communication
Revise patient intake scripts to reflect authorization review periods that may delay scheduling, medical necessity review requirements, and the possibility that authorization may be denied or require additional documentation.
5. Train Staff Across Departments
Ensure front-desk staff, schedulers, clinical documentation teams, and providers understand which procedures require authorization, applicable timelines, documentation standards, and system workflows.
How Nichols Weitzner Thomas LLP Supports Texas ASCs
At Nichols Weitzner Thomas LLP, we help Texas ASCs navigate complex Medicare authorization requirements through proactive compliance counseling. Our services include policy and procedure development, LCD documentation review, denial response and appeals, and staff training.
Our outside general counsel services allow ASCs to access ongoing compliance support without hiring additional in-house legal staff. We also assist ASCs with Stark Law compliance, Anti-Kickback Statute considerations, and healthcare reimbursement disputes.
The Bottom Line
The 2026 Medicare changes are not a coverage rollback. Epidural steroid injections, facet interventions, and spinal neurostimulators remain covered services when medically necessary. However, the administrative pathway to reimbursement has fundamentally changed.
ASCs that treat authorization as a mandatory scheduling prerequisite and enforce LCD-level documentation standards will protect revenue and maintain case throughput. Those that continue operating under retrospective review assumptions will experience increased denials and avoidable cash-flow disruption.
The implementation timeline is tight. Facilities should begin workflow revisions, staff training, and system updates immediately to ensure compliance.
Contact Nichols Weitzner Thomas LLP today to discuss your ASC’s compliance readiness and develop a customized implementation plan for the 2026 Medicare authorization requirements.
This article is provided for informational purposes only and does not constitute legal advice. Healthcare providers should consult with qualified legal counsel regarding their specific circumstances.*
